Procter & Gamble (NYSE:PG) Price Target Increased to $160.00 by Analysts at DA Davidson

Procter & Gamble (NYSE:PG) had its target price upped by DA Davidson from $159.00 to $160.00 in a report published on Monday, Benzinga reports. They currently have a neutral rating on the stock.

Several other equities research analysts have also recently issued reports on PG. Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. BNP Paribas started coverage on Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 target price for the company. Finally, StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Procter & Gamble Stock Down 1.0 %

Shares of NYSE PG opened at $169.56 on Monday. The company has a market cap of $400.18 billion, a P/E ratio of 27.71, a PEG ratio of 3.74 and a beta of 0.41. The firm has a 50-day simple moving average of $171.82 and a two-hundred day simple moving average of $167.33. Procter & Gamble has a 1 year low of $142.50 and a 1 year high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. Research analysts anticipate that Procter & Gamble will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the sale, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the second quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $29,000. Ruedi Wealth Management Inc. grew its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares during the period. POM Investment Strategies LLC purchased a new position in Procter & Gamble in the second quarter valued at $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble in the second quarter worth about $36,000. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.